Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK

MAKERS of the fat jab Wegovy say they will not increase the price of the drug when the cost of rival Mounjaro doubles next month. A price war now looms as Danish firm Novo Nordisk said it is

The National Institute for Health and Care Excellence (Nice) said people finishing treatment through the NHS must receive structured follow-up, amid growing evidence that many patients regain weight o

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa and stepping up competition with Eli Lilly's Mounjaro which launched in the country eight months ago.

Eli Lilly has rolled out a prefilled pen version of its weight-loss drug Mounjaro at the same price as vials, aiming to capture India’s growing anti-obesity market as Novo Nordisk pushes Wegovy.

Eli Lilly will increase the UK price of its Mounjaro treatment by 170% to match European markets. Despite Novo Nordisk's initial market lead with Wegovy, Mounjaro's sales have surged. The NHS will maintain access to the drug despite the price hike,

Novo Nordisk said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug Wegovy to treat a serious liver condition known as metabolic dysfunction-associated steatohepatitis.

Hyderabad: Sales of weight-loss drugs Wegovy by Danish pharmaceutical giant Novo Nordisk and Mounjaro by U.S.-based Eli Lilly doubled in India in July from a month earlier, according to data